| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
hemoglobin subunit beta | 0.494 | 0.808 | 1.2E-09 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
phenotype | 0.400 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
occludin | 0.507 | 0.846 | 8.6E-07 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
peptidase D | 0.621 | 0.769 | 1.5E-14 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
eukaryotic translation initiation factor 2 alpha kinase 1 | 0.633 | 0.577 | 7.0E-07 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
microtubule associated protein tau | 0.446 | 0.923 | 6.0E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
bradykinin receptor B1 | 0.619 | 0.731 | 4.7E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
presenilin 1 | 0.469 | 0.846 | 0.97 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
deoxyribonuclease 2, lysosomal | 0.700 | 0.462 | 4.5E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
alpha kinase 1 | 0.644 | 0.615 | 1.0E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |